| |  | Pamela Ratliff, MPA is a nationally recognized public health leader and change agent with more than 20 years of experience in research, public health, and academia. She has pioneered culturally innovative initiatives that integrate stakeholder engagement, cancer education, community partnerships, technology, and research science. Pamela currently serves as Program Director of Educational Initiatives and Partnerships at the Stanford Cancer Institute Office of Community Outreach and Engagement. Widely honored by professional organizations, community groups, academic institutions, and elected officials at the local, state, and federal levels, she is known for her visionary leadership, compassion, and unwavering commitment to health optimization and cancer control and risk mitigation. Through her work, Pamela bridges the gap between institutions and multifaceted communities, helping ensure that cultural, language, financial, and systemic barriers do not stand in the way of quality cancer care and support for all.
Each year, National Black Family Cancer Awareness Week serves as an important reminder that cancer does not affect all communities equally. A cancer diagnosis can bring tremendous uncertainty as well as many difficult decisions. For Black Americans, those challenges are often compounded by higher rates of certain cancers (breast, prostate, lung, colorectal, and cervical), later diagnoses, and lower survival rates. While progress has been made in cancer research and treatment, persistent disparities underscore the need for greater awareness and education, earlier detection, and more equitable access to care.
Cancer is the second leading cause of death in the United States, but for Black Americans, the impact is especially severe. Black men, for example, are more likely to develop and die from prostate cancer compared to any other racial or ethnic group in the United States. In addition, Black women are more likely to be diagnosed with aggressive forms of breast cancer, such as triple-negative breast cancer, and at younger ages. They are also approximately 40 percent more likely to die from breast cancer than white women. In the United States, Black women are more likely to die from cervical cancer than other women. Colorectal cancer and lung cancer also contribute significantly to higher death rates in Black communities. The disparities noted are not due to biology alone and are influenced by a range of factors, including differences in access to care, socioeconomic conditions, environmental exposures, and systemic inequities within the healthcare system. Just as importantly, delays in diagnosis and treatment often reduce the chances of successful outcomes and survival according to research supported by the Centers for Disease Control and Prevention (CDC). Read full article with additional resources here.
| 
